According to Mediq getting approved in Germany will give us approval in almost any other country. We can supposedly get drug approval much easier in Germany than we can in the USA. Sadly, we're left in the dark as to what the company's intentions are with regards to Mediq. If the trials that were mentioned in emails to a few shareholders are required we don't even know if they've begun. The company tells us virtually nothing with regards to their progress or their intentions. I still think we're waiting for the completion of the safety study in Israel before proceeding with anything else. That should be a huge catalyst for us to move forward on several fronts. I hope we learn something soon... our pps is eroding quickly and shareholders are getting impatient.